Hanson & Doremus Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$304K Hold
2,744
0.04% 159
2025
Q1
$307K Buy
2,744
+2,500
+1,025% +$280K 0.04% 155
2024
Q4
$23K Hold
244
﹤0.01% 365
2024
Q3
$20K Sell
244
-125
-34% -$10.2K ﹤0.01% 361
2024
Q2
$25K Sell
369
-1,847
-83% -$125K ﹤0.01% 356
2024
Q1
$162K Buy
2,216
+125
+6% +$9.14K 0.03% 197
2023
Q4
$169K Hold
2,091
0.03% 190
2023
Q3
$157K Buy
2,091
+50
+2% +$3.75K 0.03% 192
2023
Q2
$157K Hold
2,041
0.03% 196
2023
Q1
$169K Hold
2,041
0.04% 188
2022
Q4
$175K Hold
2,041
0.04% 189
2022
Q3
$126K Sell
2,041
-876
-30% -$54.1K 0.03% 217
2022
Q2
$180K Sell
2,917
-340
-10% -$21K 0.04% 192
2022
Q1
$194K Sell
3,257
-962
-23% -$57.3K 0.04% 191
2021
Q4
$306K Sell
4,219
-628
-13% -$45.5K 0.07% 155
2021
Q3
$339K Sell
4,847
-850
-15% -$59.4K 0.08% 136
2021
Q2
$360K Sell
5,697
-141
-2% -$8.91K 0.11% 122
2021
Q1
$377K Buy
5,838
+36
+0.6% +$2.33K 0.09% 141
2020
Q4
$338K Buy
5,802
+105
+2% +$6.12K 0.08% 139
2020
Q3
$360K Sell
5,697
-90
-2% -$5.69K 0.11% 122
2020
Q2
$445K Sell
5,787
-170
-3% -$13.1K 0.14% 114
2020
Q1
$445K Sell
5,957
-398
-6% -$29.7K 0.15% 113
2019
Q4
$413K Hold
6,355
0.12% 123
2019
Q3
$403K Sell
6,355
-298
-4% -$18.9K 0.13% 119
2019
Q2
$449K Sell
6,653
-614
-8% -$41.4K 0.14% 116
2019
Q1
$472K Buy
7,267
+189
+3% +$12.3K 0.16% 115
2018
Q4
$443K Buy
7,078
+2,123
+43% +$133K 0.16% 113
2018
Q3
$383K Buy
4,955
+216
+5% +$16.7K 0.12% 132
2018
Q2
$336K Buy
4,739
+1,033
+28% +$73.2K 0.11% 136
2018
Q1
$279K Buy
3,706
+1,245
+51% +$93.7K 0.09% 165
2017
Q4
$176K Buy
2,461
+648
+36% +$46.3K 0.06% 181
2017
Q3
$147K Buy
1,813
+1,613
+807% +$131K 0.05% 197
2017
Q2
$14K Hold
200
0.01% 398
2017
Q1
$14K Hold
200
0.01% 386
2016
Q4
$14.3K Hold
200
0.01% 362
2016
Q3
$16K Buy
200
+100
+100% +$8K 0.01% 337
2016
Q2
$8K Hold
100
﹤0.01% 376
2016
Q1
$9K Hold
100
﹤0.01% 384
2015
Q4
$10K Buy
+100
New +$10K ﹤0.01% 389